US School Has Banned All-Black Outfits (Credit: News 4 San Antonio)
Charles Middle School in Texas is facing considerable backlash after introducing a dress code that bans all-black outfits, citing mental health concerns. Principal Nick DeSantis announced the policy ahead of the school year, stating that all-black attire was linked to "depression, mental health issues, and/or criminality," as reported by USA Today. While the colour black is worn during mourning, there is no specific psychological evidence that links it to depressive episodes.
Notably, the decision has drawn widespread criticism on social media, with many questioning the link between clothing colour and students' emotional well-being. "Wearing black is not a mental health issue, it’s the way of life," wrote one user. "Wearing black is not a mental health issue, it’s the way of life," added another. Meanwhile, critics argue that changing students' clothing colour won't address underlying mental health issues. Some parents, who had already purchased black clothing for their children, voiced frustration, suggesting that the school should have consulted them before implementing such changes.
Norma De La Rosa, president of the El Paso Teachers Association, clarified that the school did not ban blacks entirely. "Charles MS students wear uniforms, and black is one of the allowed colours," De La Rosa explained. The new policy restricts students from wearing all-black outfits from head to toe to address safety concerns noted by teachers at the end of the previous school year. Notably, Superintendent Diana Sayavedra emphasized the importance of community involvement in shaping school policies. "We see this as an opportunity to engage with the community on shared values about safety and student success," Sayavedra said.
In response to the backlash, De La Rosa noted that the policy has been put on hold for further review. The school and district plan to gather additional feedback from all stakeholders to ensure that any changes align with the community's values and concerns.
Credits: Wikimedia Commons
Barry Manilow, singer, has been diagnosed with lung cancer and will be undergoing a surgery for the same. He announced this update on his social media post on Monday. Currently 82, he said he had been fighting bronchitis for more than two months, and it was when his doctor ordered an MRI that the test "discovered a cancerous spot on my left lung that needs to be removed. It is pure luck (and a great doctor) that it was found so early."
He said that doctors do not think that the cancer had spread and that he will have additional tests to confirm the diagnosis.
“No chemo, No radiation. Just chicken soup and I Love Lucy reruns,” he wrote.
However, Manilow did not mention when he would be having the surgery, however, he is expected to rest for a month to fully recover from it. This means the nine concert dates that are scheduled for January could be postponed. “Just like you, we were all looking forward to the January shows and hate having to move everything around,” he wrote. However, no other information on the rescheduled concert dates were provided.
As per the Centers for Disease Control and Prevention (CDC), lung cancer begins in the lungs and may spread to lymph nodes or other organs in the body, including brain too, if not caught early. Cancer cells from other organs too could spread to the lungs, this process is called metastases.
In lung cancer, uncontrolled growth of abnormal cells in the lung tissues, usually in the lining of air passages, forms tumors that disrupt normal breathing and can spread to other parts of the body. This is also the leading cause of cancer death.
There are several types of cancer, and in lung cancer, there are two main types called:
These types of cancer grow differently and are treated differently. Non-small cell lung cancer is more common than small cell lung cancer. Manilow, however, did not specify the type of lung cancer he has been diagnosed with, neither did he mention the stage of lung cancer he has been diagnosed with. However, he did note that the cancerous spots were found early on.
No cancer journey is the same, so people too ca have different symptoms for lung cancers. Some people may have symptoms related to lung cancer, whereas others won't feel a thing until it has spread to other parts of the body. Some people just have general symptoms of not feeling well. However, there are certain common symptoms that some people may experience, they include:
Other changes that can sometimes occur with lung cancer may include repeated bouts of pneumonia and swollen or enlarged lymph nodes (glands) inside the chest in the area between the lungs.
If you experience any of these signs, it is best that you speak to your doctor and get your tests done.
Credits: iStock
Wegovy pill is now approved by the US Food and Drug Administration (FDA). On Monday, the FDA approved a daily pill version of Novo Nordisk's weight loss drug Wegovy, which is now introducing a new option for patients, that is said to revolutionize weight loss medicine and obesity treatment.
The weight loss pill uses the same active ingredient. semaglutide. The same active ingredient powers the original Wegovy and sister drug for diabetes, Ozempic. Rival company Eli Lilly is also in the process of getting its weight loss drug approved, which will be out in the market by 2026, the CEO had said. Eli Lilly is known for drugs like Zepbound and Mounjaro. In the US, notes health policy research group KFF, at least 1 in 8 Americans are currently taking one of these medicines.
The Wegovy pill showed similar weight loss results as well as the side effects as in the Wegovy shot. The drug will be available by prescription in the US by January, said Novo Nordisk. Dr Jason Brett, who is the principal US medical head for Novo Nordisk told CNN in an interview, "We believe it will expand access and options for patients. We know there are some patients who just won’t take an injectable medication.”
The starting dose of the weight loss Wegovy pill will cost $149 for patients who will be paying out of the pocket. This is under the November agreement announced by the Trump administration. The drug will become pricier via self-pay as doses increase, though Novo Nordisk has not disclosed its prices yet. Patients whose insurance covers the medicines will be paying a lower copay.
The Wegovy weight loss pill is one of the two GLP-1 pill which will hit the market, along with Eli Lilly's orforglipron.
While the pills have not been compared head to head in an clinical trial, there have been separate studies done on them. The Wegovy pill showed an average weight loss of 14% over 64 weeks, when compared for a placebo, which showed 2% weight loss. Whereas, orforglipron showed 11% weight loss over 72 weeks on its highest dose, as compared to 2% with placebo.
Wegovy injection on the other hand showed a weight loss of 15%, whereas, Zepbound showed 21% on his highest dose. Placebo remained at 2% and 3%, respectively in comparison with both the drugs.
Side effects, including gastrointestinal issues like nausea and vomiting remain the most common ones with GLP-1 drugs, which was also seen in the studies of the pill as well. The clinical studies showed that 7% of participants on Wegovy pill stopped the treatment because of side effects, verss 6% on placebo. In orforglipron's study, up to 10% of patients stopped treatment, as compared with 3% on placebo.
The key difference with the pill is that it must be taken on an empty stomach with a small amount of water, and patients are not directed to eat, drink, or take any other medicines for the next 30 minutes after taking it.
Doctors have pointed out that a pill version of semgalutide approved for diabetes called Rybelus has not been used as widely as Ozempic in part because of these restrictions. Eli Lilly however says that in clinical trials, orforglipron was taken once a day at any time, without restrictions on food or water.
Credits: Canva
With Christmas only a week away, doctors are raising alarms over a growing “tripledemic” spreading across New York. Data shared by Northwell Health on Long Island shows a worrying rise across the state. RSV cases have increased by 35 percent, COVID cases by 15 percent, and flu has surged the most, with hospital admissions jumping 75 percent in just one week.
The festive season often brings family gatherings and travel, but it also creates the perfect setting for respiratory viruses to spread. In New York, flu, RSV and COVID cases have climbed steadily since Thanksgiving, and doctors believe numbers will continue to rise through the holidays. “Flu is increasing much faster than what we saw last year,” said Dwayne Breining, senior vice president of lab services at Northwell Health. Speaking to ABC News, Farber added that he has not seen deaths among vaccinated patients, while many severe cases involved people who were unvaccinated.
Flu season usually lasts until early spring, which means doctors say getting vaccinated now can still offer protection. Health experts also emphasise simple but effective habits such as washing hands regularly, wearing a mask if unwell, and skipping holiday events when sick to reduce the risk of spreading infections.
Common flu symptoms include a sudden fever, chills, muscle pain, headache, extreme tiredness, cough, sore throat, and a blocked or runny nose, often appearing quickly. In some cases, especially among children, vomiting or diarrhoea may also occur. Emergency warning signs include difficulty breathing, chest pain, severe dizziness, confusion, or symptoms that seem to improve but then return and worsen. These signs need urgent medical care, according to the CDC.
H3N2 Subclade K is a more altered version of the influenza A (H3N2) virus, a strain already linked to more severe illness compared to others. A subclade signals genetic changes in the virus, which may help it spread more easily or partially evade immunity gained from past infections or vaccinations.
RSV, short for Respiratory Syncytial Virus, is a highly contagious virus that commonly causes respiratory infections. While it often feels like a mild cold, it can lead to serious breathing issues in infants, older adults, and people with weakened immunity. The virus affects the nose, throat and lungs. Most children catch RSV by the age of two, but repeat infections are common. Symptoms include cough, runny nose, fever and wheezing, and medical help is needed if breathing becomes difficult.
New York City is currently reporting some of the highest flu-like illness levels in the country. States such as Alabama, Colorado, Connecticut, Hawaii, Louisiana, Maryland, Minnesota, New Hampshire, New Jersey, Ohio, Rhode Island and Texas are seeing moderate respiratory illness activity. All other states remain at low or very low levels. The CDC estimates that this flu season has already resulted in at least 4.6 million illnesses, around 49,000 hospitalisations and approximately 1,900 deaths nationwide.
© 2024 Bennett, Coleman & Company Limited